VolitionRx Limited Costs and Expenses
VolitionRx Limited (VNRX) reported Costs and Expenses of $803.21 thousand for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostsAndExpenses · last filed 2022-05-11
- VolitionRx Limited costs and expenses for the quarter ending 2022-03-31 was $803.21K.
| Period end | Costs and Expenses 3 month | Costs and Expenses 9 month |
|---|---|---|
| 2022-03-31 | $803.21K 10-Q · filed 2022-05-11 | |
| 2021-09-30 | $190.98K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |